SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,820,311 | -12.7% | 2,314,783 | -4.8% | 0.02% | -8.7% |
| Q2 2023 | $73,073,115 | -15.7% | 2,430,916 | +1.7% | 0.02% | -20.7% |
| Q1 2023 | $86,635,795 | +101806.5% | 2,391,266 | +0.3% | 0.03% | +16.0% |
| Q4 2022 | $85,015 | -99.9% | 2,383,345 | +5.0% | 0.02% | -16.7% |
| Q3 2022 | $76,854,000 | +18.7% | 2,270,480 | +1.4% | 0.03% | +30.4% |
| Q2 2022 | $64,753,000 | -9.8% | 2,239,125 | +0.8% | 0.02% | +4.5% |
| Q1 2022 | $71,793,000 | +9.9% | 2,221,320 | -0.9% | 0.02% | +10.0% |
| Q4 2021 | $65,339,000 | +7.7% | 2,240,621 | -1.5% | 0.02% | 0.0% |
| Q3 2021 | $60,676,000 | -13.4% | 2,275,051 | -0.0% | 0.02% | -9.1% |
| Q2 2021 | $70,086,000 | +25.6% | 2,276,185 | +6.8% | 0.02% | +22.2% |
| Q1 2021 | $55,818,000 | +14.7% | 2,132,092 | +10.2% | 0.02% | 0.0% |
| Q4 2020 | $48,681,000 | +18.9% | 1,934,863 | -1.5% | 0.02% | +5.9% |
| Q3 2020 | $40,947,000 | -12.0% | 1,964,835 | +0.2% | 0.02% | -15.0% |
| Q2 2020 | $46,548,000 | +42.4% | 1,960,011 | +7.9% | 0.02% | +17.6% |
| Q1 2020 | $32,683,000 | -17.1% | 1,816,890 | +9.3% | 0.02% | +21.4% |
| Q4 2019 | $39,422,000 | -10.5% | 1,662,007 | +3.7% | 0.01% | -17.6% |
| Q3 2019 | $44,043,000 | -7.6% | 1,602,710 | +11.3% | 0.02% | -10.5% |
| Q2 2019 | $47,659,000 | -1.3% | 1,440,331 | +4.5% | 0.02% | 0.0% |
| Q1 2019 | $48,304,000 | +10.7% | 1,378,566 | +4.9% | 0.02% | -5.0% |
| Q4 2018 | $43,642,000 | -35.1% | 1,313,761 | -1.6% | 0.02% | -23.1% |
| Q3 2018 | $67,211,000 | -16.8% | 1,334,891 | -1.1% | 0.03% | -18.8% |
| Q2 2018 | $80,795,000 | +25.6% | 1,349,984 | -3.8% | 0.03% | +18.5% |
| Q1 2018 | $64,303,000 | +15.3% | 1,403,994 | +0.3% | 0.03% | +17.4% |
| Q4 2017 | $55,758,000 | +10.0% | 1,399,150 | +10.4% | 0.02% | +4.5% |
| Q3 2017 | $50,696,000 | -7.2% | 1,267,424 | -0.1% | 0.02% | -12.0% |
| Q2 2017 | $54,654,000 | +52.4% | 1,268,082 | +10.6% | 0.02% | +47.1% |
| Q1 2017 | $35,871,000 | +28.3% | 1,146,040 | +3.5% | 0.02% | +21.4% |
| Q4 2016 | $27,952,000 | +7.1% | 1,107,007 | +4.9% | 0.01% | 0.0% |
| Q3 2016 | $26,102,000 | +23.0% | 1,055,496 | +1.3% | 0.01% | +16.7% |
| Q2 2016 | $21,226,000 | +32.8% | 1,042,016 | -0.6% | 0.01% | +20.0% |
| Q1 2016 | $15,979,000 | +9.4% | 1,047,813 | -3.6% | 0.01% | +11.1% |
| Q4 2015 | $14,610,000 | +7.4% | 1,087,055 | +12.1% | 0.01% | 0.0% |
| Q3 2015 | $13,602,000 | +59.0% | 969,481 | +92.4% | 0.01% | +80.0% |
| Q2 2015 | $8,557,000 | – | 503,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |